초음파 내시경 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of Endoscopic Ultrasound (EUS) Market

The global Endoscopic Ultrasound (EUS) Market was valued at USD 1.65 billion in 2025 and is projected to reach USD 1.79 billion in 2026 and USD 3.32 billion by 2034. The market is expected to expand at a CAGR of 8.06% during 2026-2034. North America dominated the global market with a 35.75% market share in 2025. Endoscopic ultrasound is a minimally invasive technology that combines endoscopy and high-frequency ultrasound to generate detailed images of the digestive tract, surrounding organs, and tissues. It supports both diagnostic and therapeutic procedures, particularly in gastrointestinal and pancreatic diseases.

The increasing prevalence of gastrointestinal disorders, stomach cancer, pancreatic conditions, and other digestive diseases is strengthening demand for EUS systems. Growing awareness of early cancer diagnosis, increasing endoscopic procedures, and a rising number of trained endoscopists are also supporting market growth.

Endoscopic Ultrasound Market Trends

A major Endoscopic Ultrasound Market Trend is the development of technologically advanced systems that improve diagnostic accuracy and clinical outcomes. EUS-guided fine-needle aspiration has become an important minimally invasive technique, particularly for detecting pancreatic cancer and other gastrointestinal abnormalities.

The market is also benefiting from new product launches, improved ultrasound probes, advanced imaging systems, and better endoscopic processors. Training initiatives and collaborations between manufacturers and medical organizations are further increasing the availability of skilled professionals capable of performing EUS procedures.

Market Growth Drivers and Opportunities

The growing prevalence of gastrointestinal diseases represents a key Endoscopic Ultrasound Market Growth driver. Increasing cancer incidence, an aging population, and the need for earlier and more accurate diagnosis are encouraging healthcare providers to adopt minimally invasive technologies.

The expansion of healthcare infrastructure in emerging economies is creating additional Endoscopic Ultrasound Market Opportunities. Increasing healthcare spending, improved access to diagnostic services, and wider distribution networks are supporting adoption in Asia Pacific, Latin America, and the Middle East & Africa.

Technological advancements also represent a significant opportunity. Manufacturers are focusing on high-frequency ultrasound probes, advanced imaging capabilities, and EUS-guided therapeutic applications.

Endoscopic Ultrasound Market Segmentation

By Product: The market is segmented into endoscopes, ultrasound probes, ultrasound processors, imaging systems, endoscopic ultrasound needles, and accessories. Endoscopes represented the leading product segment, supported by increasing EUS procedures and the expansion of major manufacturers into developing markets. The endoscopes segment accounted for 52.3% in 2018.

By Application: The market includes oncology, pancreatic conditions, and others. Oncology is expected to witness strong growth due to the rising incidence of gastrointestinal cancers and growing demand for minimally invasive diagnostic tools. Pancreatic conditions are also projected to grow significantly as awareness and accessibility of pancreatic diagnostics improve.

By End User: The market is divided into hospitals, ambulatory surgery centers, and others. Hospitals are expected to maintain dominance due to favorable reimbursement for minimally invasive procedures, increasing numbers of qualified endoscopists, and the availability of advanced healthcare infrastructure.

Regional Endoscopic Ultrasound Market Analysis

North America held the leading position with a 35.75% share in 2025. Advanced healthcare infrastructure, high procedure volumes, increasing adoption of sophisticated diagnostic technologies, and the availability of trained professionals support regional dominance.

Europe is expected to experience steady growth, supported by government initiatives for cancer diagnosis, strategic collaborations, and increasing use of EUS in hospitals.

Asia Pacific is projected to witness significant growth due to rising cancer awareness, population aging, improving healthcare infrastructure, favorable diagnostic guidelines, and expanding distribution networks. Japan is particularly important because of the presence of major manufacturers such as Olympus Corporation and Fujifilm Holdings.

The U.S. remains a major contributor to the North American market because of advanced diagnostic capabilities, high healthcare expenditure, and widespread endoscopic procedures.

Competitive Landscape

The Endoscopic Ultrasound Market is consolidated, with leading companies focusing on product development, strategic partnerships, distribution expansion, and technological innovation. Major players include Olympus Corporation, PENTAX Medical, FUJIFILM Holdings Corporation, Cook Medical, Boston Scientific Corporation, Medtronic, Medi-Globe GmbH, and CONMED Corporation.

Olympus Corporation holds a strong position due to its diversified product portfolio and established global distribution network. PENTAX Medical has also maintained a significant presence through strategic partnerships for EUS products.

Conclusion

The global Endoscopic Ultrasound Market is positioned for sustained expansion, increasing from USD 1.65 billion in 2025 to USD 1.79 billion in 2026 and reaching USD 3.32 billion by 2034. Rising gastrointestinal diseases, increasing cancer diagnosis requirements, technological advancements, and the shift toward minimally invasive procedures will remain central to market development. North America will continue to be a major market, while Asia Pacific offers substantial growth opportunities. Continued innovation in endoscopes, imaging systems, ultrasound probes, and EUS-guided therapeutic procedures is expected to strengthen the Endoscopic Ultrasound Market Outlook through 2034.

Unit Value (USD Million)

Segmentation By Product

• Endoscopes
  • Radial Endoscopes
  • Linear Endoscopes
• Ultrasound Probes
• Ultrasonic Processors
• Imaging Systems
• Needles
• Accessories

By Application

• Oncology
• Pancreatic Conditions
• Others

By End User

• Hospitals
• Ambulatory Surgery Centers
• Others

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• The Middle East and Africa ( South Africa, GCC, and Rest of Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Technology Advancements in Endoscopy Ultrasound, 2025
• 4.2. Pricing Analysis, By Region, 2025
• 4.3. Overview on Diagnostic and Therapeutic Roles of Endoscopy Ultrasound
• 4.4. Key Product/Brand Analysis, For Key Players

5. Global Endoscopic Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Product
  • 5.2.1. Endoscopes
    • 5.2.1.1. Radial Endoscopes
    • 5.2.1.2. Linear Endoscopes
  • 5.2.2. Ultrasound Probes
  • 5.2.3. Ultrasonic Processors
  • 5.2.4. Imaging Systems
  • 5.2.5. Needles
  • 5.2.6. Accessories
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Oncology
  • 5.3.2. Pancreatic Conditions
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals
  • 5.4.2. Ambulatory Surgery Centers
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Endoscopic Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis, Insights and Forecast - By Product
  • 6.2.1. Endoscopes
    • 6.2.1.1. Radial Endoscopes
    • 6.2.1.2. Linear Endoscopes
  • 6.2.2. Ultrasound Probes
  • 6.2.3. Ultrasonic Processors
  • 6.2.4. Imaging Systems
  • 6.2.5. Needles
  • 6.2.6. Accessories
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Oncology
  • 6.3.2. Pancreatic Conditions
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Hospitals
  • 6.4.2. Ambulatory Surgery Centers
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Endoscopic Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis, Insights and Forecast - By Product
  • 7.2.1. Endoscopes
    • 7.2.1.1. Radial Endoscopes
    • 7.2.1.2. Linear Endoscopes
  • 7.2.2. Ultrasound Probes
  • 7.2.3. Ultrasonic Processors
  • 7.2.4. Imaging Systems
  • 7.2.5. Needles
  • 7.2.6. Accessories
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Oncology
  • 7.3.2. Pancreatic Conditions
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Hospitals
  • 7.4.2. Ambulatory Surgery Centers
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Countries/ Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Endoscopic Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis, Insights and Forecast - By Product
  • 8.2.1. Endoscopes
    • 8.2.1.1. Radial Endoscopes
    • 8.2.1.2. Linear Endoscopes
  • 8.2.2. Ultrasound Probes
  • 8.2.3. Ultrasonic Processors
  • 8.2.4. Imaging Systems
  • 8.2.5. Needles
  • 8.2.6. Accessories
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Oncology
  • 8.3.2. Pancreatic Conditions
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Hospitals
  • 8.4.2. Others
• 8.5. Market Analysis, Insights and Forecast - By Countries/ Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Endoscopic Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis, Insights and Forecast - By Product
  • 9.2.1. Endoscopes
    • 9.2.1.1. Radial Endoscopes
    • 9.2.1.2. Linear Endoscopes
  • 9.2.2. Ultrasound Probes
  • 9.2.3. Ultrasonic Processors
  • 9.2.4. Imaging Systems
  • 9.2.5. Needles
  • 9.2.6. Accessories
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Oncology
  • 9.3.2. Pancreatic Conditions
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Hospitals
  • 9.4.2. Others
• 9.5. Market Analysis, Insights and Forecast - By Countries/ Sub regions
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Endoscopic Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis, Insights and Forecast - By Product
  • 10.2.1. Endoscopes
    • 10.2.1.1. Radial Endoscopes
    • 10.2.1.2. Linear Endoscopes
  • 10.2.2. Ultrasound Probes
  • 10.2.3. Ultrasonic Processors
  • 10.2.4. Imaging Systems
  • 10.2.5. Needles
  • 10.2.6. Accessories
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Oncology
  • 10.3.2. Pancreatic Conditions
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Hospitals
  • 10.4.2. Others
• 10.5. Market Analysis, Insights and Forecast - By Countries/ Sub region
  • 10.5.1. South Africa
  • 10.5.2. GCC
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Company Profiles
  • 11.3.1. Olympus Corporation
    • 11.3.1.1. Overview,
    • 11.3.1.2. Products & Services,
    • 11.3.1.3. SWOT analysis,
    • 11.3.1.4. Recent developments,
    • 11.3.1.5. strategies,
    • 11.3.1.6. financials (based on availability)
  • 11.3.2. PENTAX Medical
    • 11.3.2.1. Overview,
    • 11.3.2.2. Products & Services,
    • 11.3.2.3. SWOT analysis,
    • 11.3.2.4. Recent developments,
    • 11.3.2.5. strategies,
    • 11.3.2.6. financials (based on availability)
  • 11.3.3. FUJIFILM Holdings Corporation
    • 11.3.3.1. Overview,
    • 11.3.3.2. Products & Services,
    • 11.3.3.3. SWOT analysis,
    • 11.3.3.4. Recent developments,
    • 11.3.3.5. strategies,
    • 11.3.3.6. financials (based on availability)
  • 11.3.4. Cook Medical
    • 11.3.4.1. Overview,
    • 11.3.4.2. Products & Services,
    • 11.3.4.3. SWOT analysis,
    • 11.3.4.4. Recent developments,
    • 11.3.4.5. strategies,
    • 11.3.4.6. financials (based on availability)
  • 11.3.5. Boston Scientific Corporation
    • 11.3.5.1. Overview,
    • 11.3.5.2. Products & Services,
    • 11.3.5.3. SWOT analysis,
    • 11.3.5.4. Recent developments,
    • 11.3.5.5. strategies,
    • 11.3.5.6. financials (based on availability)
  • 11.3.6. Medtronic
    • 11.3.6.1. Overview,
    • 11.3.6.2. Products & Services,
    • 11.3.6.3. SWOT analysis,
    • 11.3.6.4. Recent developments,
    • 11.3.6.5. strategies,
    • 11.3.6.6. financials (based on availability)
  • 11.3.7. Medi-Globe GmbH
    • 11.3.7.1. Overview,
    • 11.3.7.2. Products & Services,
    • 11.3.7.3. SWOT analysis,
    • 11.3.7.4. Recent developments,
    • 11.3.7.5. strategies,
    • 11.3.7.6. financials (based on availability)
  • 11.3.8. CONMED Corporation
    • 11.3.8.1. Overview,
    • 11.3.8.2. Products & Services,
    • 11.3.8.3. SWOT analysis,
    • 11.3.8.4. Recent developments,
    • 11.3.8.5. strategies,
    • 11.3.8.6. financials (based on availability)
  • 11.3.9. Other Prominent Players
    • 11.3.9.1. Overview,
    • 11.3.9.2. Products & Services,
    • 11.3.9.3. SWOT analysis,
    • 11.3.9.4. Recent developments,
    • 11.3.9.5. strategies,
    • 11.3.9.6. financials (based on availability)

12. Strategic Recommendations